Temozolomide
- 期刊名称Reactions Weekly
- 作者Ozdemir, Utkan; Ozbay, Ismail; Ozbay, Bilge; Veli, Sevil
- 卷第1454卷
- 期第1期
- 印刷ISSN0114-9954
- 电子ISSN1179-2051
- 文件大小127.41KB
- 发表时间2013-06
- DOI10.1007/s40278-013-3550-7
- 页码40-40
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trialBertrand Coiffier; Evgenii A Osmanov; Xiaonan Hong; Adriana Scheliga; Jiri Mayer; Fritz Offner; Simon Rule; Adriana Teixeira; Jan Walewski; Sven de Vos; Michael Crump; Ofer Shpilberg; Dixie-Lee Esseltine; Eugene Zhu; Christopher Enny; Panteli Theocharous; Helgi van de Velde; Yusri A Elsayed; Pier Luigi Zinzani · 2011
061. Rituximab-Associated Neutropaenia: Safety of Retreatment Rituximab TherapyRheumatology · 2015
Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trialPier Luigi Zinzani, Nuriet K Khuageva, Huaqing Wang, Bernardo Garicochea, Jan Walewski, Achiel Van Hoof, Pierre Soubeyran, Dolores Caballero, Rena Buckstein, Dixie-Lee Esseltine, Panteli Theocharous, Christopher Enny, Eugene Zhu, Yusri A Elsayed, Bertrand Coiffier · 2012
The Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment with Rituximab or a Rituximab-Containing Regimen in ColombiaBertwistle, D.; Munakata, J.; Wehler, E; Leyva, V.; Ariza, J.G.; Zambrano, C.; Gonzalez, L. · Value in Health · 2013
The Cost-Effectiveness of Bendamustine-Rituximab Versus Fludarabine-Rituximab for Patients with Indolent Non-Hodgkin’s Lymphoma (INHL) Who Have Progressed Following Treatment with Rituximab or a Rituximab-Containing Regimen in MexicoBertwistle, D.; Munakata, J.; Wehler, E.; Leyva, V.; Valencia, A.; Hernandez, A.; de la Torre, L.; Gonzalez, L. · Value in Health · 2013
Is Rituximab Infusion Getting Easier? (Is it Safe to Give Rituximab Faster?)S. Vieira; D. Monroe · 2011
Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimenSteven P. Treon; Christina Hanzis; Robert J. Manning; Leukothea Ioakimidis; Christopher J. Patterson; Zachary R. Hunter; Patricia Sheehy; Barry Turnbull · 2011
Are skin tests to Rituximab a risk marker for Rituximab hypersensivity?Galvis, Jonnathan Acevedo; Solano, Emilio; Zepeda, Cristiana Solorzano; De La Hoz, Belen · Journal of Allergy and Clinical Immunology · 2020
Cixutumumabzu Ermgassen, P. S. E.; Gray, M. W.; Langdon, C. J.; Spalding, M. D.; Brumbaugh, R. D. · Reactions Weekly · 2013
Quantifying the historic contribution of Olympia oysters to filtration in Pacific Coast (USA) estuaries and the implications for restoration objectiveszu Ermgassen, P. S. E.; Gray, M. W.; Langdon, C. J.; Spalding, M. D.; Brumbaugh, R. D. · Aquatic Ecology · 2013
Biperiden/trihexyphenidylReactions Weekly · 1995
NitrendipineReactions Weekly · 2003
ScopolamineReactions Weekly · 2007
ScopolamineReactions Weekly · 2012
ScopolamineReactions Weekly · 2009
Centella asiaticaReactions Weekly · 2011
Daunorubicin/mitoxantroneReactions Weekly · 2007
AnthracyclinesReactions Weekly · 1991